Bharat Biotech gets nod for Phase-3 trial for nasal Covid vaccine as booster shot
Hyderabad, Jan 28 : Bharat Biotech (BB), a global leader in vaccine innovation and developer of vaccines for infectious diseases, Today said it has got approval from India's drug regulator for the phase-3 clinical trials…